TriOptimize II: The Use of Blood Eosinophil Count in the Care of Patients with COPD Prescribed Single Inhaler Triple Therapy: A Real-World View from Germany

被引:0
|
作者
Hoevelmann, R. [1 ]
Javan, S. Bahari [1 ]
Melchior, K. [1 ]
Gessner, C. [2 ]
Pfeffermann, A. [1 ]
机构
[1] Chiesi GmbH, Med Affairs, Hamburg, Germany
[2] POIS Leipzig GbR, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4879
引用
收藏
页数:1
相关论文
共 50 条
  • [1] TriOptimize II: The Use of Blood Eosinophil Count in the Care of Patients with COPD Prescribed Single Inhaler Therapy: A Real-World View from Germany
    Hoevelmann, R.
    Javan, Bahari S.
    Melchior, K.
    Pfeffermann, A.
    Gessner, C.
    [J]. PNEUMOLOGIE, 2020, 74 : S43 - S43
  • [2] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
    Gessner, C.
    Akyildiz, B.
    Nachtigall, D.
    Nudo, E.
    Boeing, S.
    Timmermann, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [3] Trioptimize VI: The Use of Extrafine Single Inhaler Triple Therapy Improves Adherence to Treatment in Patients with COPD - Real-World Evidence
    Hoevelmann, R.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Criee, C.
    Gessner, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] TriOptimize III: Extrafine single inhaler Triple Therapy in COPD improves health-related quality of life in a real-world setting in Germany
    Hoevelmann, R.
    Georges, G.
    Javan, Bahari S.
    Melchior, K.
    Criee, C. P.
    Gessner, C.
    [J]. PNEUMOLOGIE, 2020, 74 : S43 - S43
  • [5] Trioptimize V: Improvement of Air Flow and Resistance in Patients with COPD Treated with Extrafine Single Inhaler Triple Therapy in a Real-World Setting
    Georges, G.
    Criee, C.
    Hoevelmann, R.
    Javan, S. Bahari
    Melchior, K.
    Gessner, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [6] TriOptimize X: Improved adherence by extrafine single-inhaler triple therapy in real-world
    Criee, C.
    Trinkmann, F.
    Gueldenring, S.
    Loeper, N.
    Bogoevska, V
    Gessner, C.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Trioptimize IV: Improvement of Health-Related Quality of Life in Patients with COPD Treated with Extrafine Single Inhaler Triple Therapy in a Real-World Setting
    Gessner, C.
    Criee, C.
    Georges, G.
    Javan, S. Bahari
    Melchior, K.
    Hoevelmann, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [8] TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting
    Gessner, Christian
    Javan, Sanaz Bahari
    Hoevelmann, Raimund
    Georges, George
    Melchior, Kai
    Criee, Carl-Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [9] Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity
    Eilat-Tsanani, Sophia
    Ernst, Pierre
    Suissa, Samy
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 21 (01)
  • [10] Are patients with COPD more adherent to single-inhaler compared with multiple-inhaler triple therapy in a real-world UK primary care treated population?
    Rothnie, Kieran
    Czira, Alexandrosz
    Compton, Chris
    Banks, Vicky
    Wood, Robert
    Tritton, Theo
    Thomas, Joseph
    Massey, Olivia
    Blackburn, Stuart
    Wild, Rosie
    Ismaila, Afisi
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58